Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-20-004639
Filing Date
2020-02-24
Accepted
2020-02-24 16:33:11
Documents
9
Effectiveness Date
2020-02-24

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82020_aytubioscience.htm S-8 484238
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES H CO fs82020ex3-12_aytubio.htm EX-3.12 87697
3 AMENDED AND RESTATED BYLAWS fs82020ex3-13_aytubio.htm EX-3.13 123608
4 OPINION OF DORSEY & WHITNEY LLP fs82020ex5-1_aytubio.htm EX-5.1 4939
5 CONSENT OF PLANTE & MORAN, PLLC RELATING TO AYTU'S FINANCIAL STATEMENTS fs82020ex23-2_aytubio.htm EX-23.2 3415
6 CONSENTOF HALL & COMPANY RELATING TO INNOVUS' FINANCIAL STATEMENTS fs82020ex23-3_aytubio.htm EX-23.3 2132
7 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS OF THE ABBREVIATED FINANCIAL fs82020ex23-4_aytubio.htm EX-23.4 1972
8 CONSENT OF EKS&H LLLP, PREDECESSOR INDEPENDENT PUBLIC ACCOUNTING FIRM, RELATING fs82020ex23-5_aytubio.htm EX-23.5 3558
9 GRAPHIC ex23-3_001.jpg GRAPHIC 29674
  Complete submission text file 0001213900-20-004639.txt   753783
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-236598 | Film No.: 20644804
SIC: 2834 Pharmaceutical Preparations